Acuta Capital Partners, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $70.3 Million distributed in 39 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $9.49M, Insmed Inc with a value of $7.24M, Crinetics Pharmaceuticals, Inc. with a value of $6.28M, Aadi Bioscience, Inc. with a value of $5.84M, and Revolution Medicines, Inc. with a value of $4.89M.

Examining the 13F form we can see an decrease of $28.4M in the current position value, from $98.8M to 70.3M.

Acuta Capital Partners, LLC is based out at Belmont, CA

Below you can find more details about Acuta Capital Partners, LLC portfolio as well as his latest detailed transactions.

Portfolio value $70.3 Million
Healthcare: $70.3 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 39
  • Current Value $70.3 Million
  • Prior Value $98.8 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 8 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.